Nitric Oxide Innovations Drug Company Founder and CEO, Nathan Bryan Ph.D, Engages Alan Morell, Creative Management Partners (CMP), as Senior Advisor for Worldwide Licensing, Media Positioning Representation
BEVERLY HILLS, CA, June 16, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Announced today: Nitric Oxide Innovationsdrug companyCEO, Nathan Bryan Ph.D,engages Alan Morell, Creative Management Partners (CMP) as Senior Advisorfor Worldwide Licensing, Media positioning, representation of Dr. Bryans Literary, Broadcast, Consulting and Speaking Engagements.
- BEVERLY HILLS, CA, June 16, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Announced today: Nitric Oxide Innovationsdrug companyCEO, Nathan Bryan Ph.D,engages Alan Morell, Creative Management Partners (CMP) as Senior Advisorfor Worldwide Licensing, Media positioning, representation of Dr. Bryans Literary, Broadcast, Consulting and Speaking Engagements.
- Said Nathan S. Bryan Ph.D: "Nitric Oxide Innovations is a clinical stage pharmaceutical company focused on nitric oxide based therapeutics.
- NOviricid is a nitric oxide releasing lozenge designed to replete and restore nitric oxide in patients that are nitric oxide deficient and therefore at increased risk of illness from COVID.
- Our NOviricid drug is a nitric oxide donor that releases 40ppm nitric oxide gas over 5 minutes as the lozenge is dissolving.